Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE
Quantification of <sup>68</sup>Ga-DOTATOC PET/CT-derived parameters offers limited prognostic value for OS in NET patients who are receiving PRRT in clinical practice. These findings might emphasize the current robust integration of imaging in clinical decision-making for NET management.
Authors
- Matthias Miederer (ORCID: https://orcid.org/0000-0001-5075-5995)
- Christian Fottner (ORCID: https://orcid.org/0000-0002-0091-0755)
- Michael Schroeder (ORCID: https://orcid.org/0000-0003-2848-6949)
- Simin Schadmand‐Fischer
- Mathias Schreckenberger
- C Louise Wise
- Thomas J. Musholt (ORCID: https://orcid.org/0000-0002-4498-7439)
- Matthias M. Weber (ORCID: https://orcid.org/0000-0002-6939-2255)
- Ali Al-Fatlawi
- Stephan Raad
Institutions
- Johannes Gutenberg University Mainz (DE)
- Helmholtz-Zentrum Dresden-Rossendorf (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University Hospital Carl Gustav Carus (DE)
- Artificial Intelligence in Medicine (Canada) (CA)
- University of Kufa (IQ)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s40644-025-00899-5
- Citations
- 2
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Technische Universität Dresden